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Endovascular repair of blunt thoracic aortic injury:
Techniques and tips
Mark A. Farber, MD, and Robert R. Mendes, MD, Chapel Hill, NCSince the initial report1 of treating blunt aortic injuries
(BAI) with endovascular methods, its application in the
traumatically injured patient has continued to gain accep-
tance and use. This may be attributed to an increase in the
number of available thoracic stent grafts as well as the
accumulation of experience by endovascular specialists. Ad-
ditionally, experience has revealed several important proce-
dural details that help ensure a successful result. This article
describes the techniques and tips that may be useful to
optimize outcomes for this high-risk group of patients.
EVALUATION
Over the past decade, diagnostic evaluation associated
with trauma patients has rapidly progressed to multidetec-
tor spiral computed tomography (CT) imaging for the vast
majority of injuries. While a recent report claims that CT
scanning has supplanted aortography as the gold standard
for diagnosing BAI2, there are shortcomings of axial imag-
ing that warrant mention. CT imaging should be per-
formed with 1-2 mm intervals to optimize the detection
and evaluation of intimal defects of the aorta. However,
due to emergent conditions and the need to obtain images
of multiple body regions (head, neck, chest, abdomen/
pelvis) this sometimes cannot be accomplished, and 3-5
mm intervals are used. As such, axial images can bemislead-
ing or suboptimal when evaluating the aorta in the typical
location for BAI, the isthmus. Therefore, it is critical that
three-dimensional and centerline reconstructions be per-
formed to identify not only the location of the injury but
also accurately measure the aortic diameter and the distance
from branched vessels. In cases where thoracic imaging is
suboptimal or pelvic imaging (to appropriately evaluate the
iliac arteries) is missing, it has been our practice to perform
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doi:10.1016/j.jvs.2009.01.009a second, more detailed CT. In instances where femoral
access is felt to be too small for delivery of the stent graft,
iliac or aortic conduits can be utilized. Conduits should be
avoided, however, in patients with pelvic fractures or hema-
tomas.
If the lesion location requires coverage of the left
subclavian artery (SCA), then additional imaging will be
required to determine if the patient possesses dominant left
vertebral artery (VA) architecture. This will either involve
additional CT imaging of the head and neck or intraoper-
ative bilateral vertebral angiography. Whether left SCA
coverage is required will depend upon the location of the
lesion and the degree of aortic curvature. The absolute and
relative indications for left SCA revascularization at our
institution are listed in the Table. It has been our practice to
maintain left SCA antegrade perfusion in cases where the
patient has left VA dominance. Our approach is to use a
parallel stent technique (Fig 1) instead of performing a
carotid to SCA bypass or transposition. This technique has
been successful as most lesions from BAI are along the
inferior curve of the aorta and placing a bare stent from the
subclavian along the superior aspect of the aorta has not
increased the incidence of type Ia endoleaks in our experi-
ence.
Access for intraprocedural angiographic visualization
also warrants some discussion. In most cases, access
through the left brachial artery provides excellent interro-
gation of the great vessel origins and the vertebral arteries.
If parallel stenting is necessary, sheath access is already
established prior to stent graft deployment. In cases where
the left SCA perfusion is not a concern, access can be
accomplished by either the ipsilateral or contralateral fem-
oral artery depending upon the vessel diameter and delivery
catheter size.
DEVICE SELECTION
Until recently (June 2008), only the Gore TAG device
(W. L. Gore and Associates, Flagstaff, Ariz) was approved
for implantation in to the thoracic aorta for aneurysmal
disease. While its use for BAI is considered off-label, it has
been used successfully with few exceptions or complica-
tions. There are now three devices commercially approved
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ment of aortic sizes between 18 mm and 42 mm in diam-
eter. While each of the three devices has different proximal
and distal configurations, none of them has a disease spe-
cific indication for treating aortic transections. As such,
they are prone to certain device specific complications.
Prior to June 2008, when the endovascular specialist
encountered a patient with an aortic intimal diameter less
than 23mm, infrarenal aortic cuffs were typically utilized to
exclude the lesion.3,4 This allowed better device apposition
against the inferior wall of the aortic arch and eliminated
oversizing that in certain instances lead to device collapse.5
While criteria for oversizing and neck lengths have not been
established through clinical trials, endovascular experts
consider the traditional oversizing seen with aneurysmal
disease not as crucial since device migration is not a signif-
icant concern. Typically, devices are oversized approxi-
mately 10% for the treatment of BAI. Proximal neck length
should be adequate to achieve exclusion of the lesion and
may be impacted by the radius of curvature of the aorta.
This can be achieved with less proximal neck length than
the instructions for use recommends. Device positioning is
governed by aortic curvature to ensure that the device
aligns parallel to the aortic centerline rather than the spe-
cific position relative to the left SCA. While the addition of
two new devices extends the treatment options for BAI,
adequate devices with tapered configurations to treat small
aortas are still not available.
PROCEDURAL DETAILS
The patient is typically taken to the operating room in
an expeditious fashion. While the procedure can be under-
taken with local or regional anesthesia, most patients re-
ceive general anesthesia, unless contraindications exist, al-
lowing for better control of breathing patterns during
subtracted angiography of the chest. The procedure can be
performed with or without heparin if necessary. In our
institution, heparin is given at 80 units/kg unless contra-
indicated (associated closed head injury or other high risks
for bleeding). Typically, stiff wires are used during the
procedure (Lunderquist [Cook Inc, Bloomington, Ind] or
Meier [Boston Scientific, Natick,Mass]) and retroflexed off
the aortic valve. Once this has been established, the device
can be brought up near the intended implantation site.
Once appropriate angles and orientation is determined,
Table. Indications for left subclavian revascularization
Absolute indications
Left inferior mammary artery bypass
Stenotic or occluded right vertebral artery
Left vertebral terminating in the posterior inferior cerebellar
artery
Left vertebral arising from the arch
Relative indications
Left-hand dominant individuals
Large left vertebral in comparison to the right
Extensive thoracic coveragethen the device is deployed under fluoroscopic guidance.Correct image intensifier orientation and angle is criti-
cal for precise device placement. Angiographic delineation
of the anatomy is achieved with a perpendicular view to the
aortic arch (usually 35to 50 degrees left anterior oblique
Fig 1. a, Angiogram revealing left subclavian artery occlusion.
b, Left subclavian artery parallel stent deployment. c, Thoracic
angiogram revealing antegrade left subclavian artery (SCA) perfu-
sion, lesion exclusion.views). If necessary, vertebral angiography can also be
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was not obtained prior to surgery and left SCA coverage is
planned. The final device orientation should approach a
parallel configuration of the proximal stents with respect to
the aortic centerline and achieve lesion exclusion (Fig 2).
While some vascular specialists advocate reducing the
mean blood pressure during deployment of thoracic de-
vices, we have found it to be both device and disease specific
and do not routinely employ its use. In cases where the
patient is very hyperdynamic and the device cannot be
positioned along the outer curve to enable precise deploy-
ment, reducing blood pressure with either inflow occlusion
balloons or pharmacologic means may be helpful in achiev-
ing a more accurate deployment.
While there is no published follow-up protocol cur-
rently, we routine follow our patients at 1, 6, and 12
months and then yearly for the first 5 years. After 5 years,
we have been more liberal with our follow-up intervals and
Fig 2. a, Deployment of proximal thoracic stent graft in parallel
orientation. b, Completion angiogram after deployment.have extended it to every 2 to 3 years with noncontrastedimaging to reduce the life-long radiation exposure to the
patient.
CLINICAL EXPERIENCE
Prior to the advent of endovascular therapy for BAI,
there was a trend to delay the open repair of some injuries
until the patient was relatively stable. However, this was not
without some increased risk for rupture.6 Since the advent
of thoracic endovascular aneurysm repair (TEVAR), we
have rarely delayed the repair of a blunt aortic injury. On
occasion when there is no periaortic hematoma and a small
intimal defect is seen on CT imaging, we have observed and
re-imaged the patient several days later to monitor the
lesion.
We have now performed over 25 endovascular aortic
repairs for aortic transection with several different devices.4
A recent meta-analysis of open vs endovascular repair re-
ported several significant findings that are import to high-
light.7 Seventeen retrospective studies were reviewed over a
4-year period between 2003 and 2007.While all the studies
were nonrandomized, there were a total of 589 patients
treated (369 open and 220 endovascular). The average
time to repair was 1.5 vs 1 day, respectively, and was not
statistically different between the two groups. Even though
injury severity score was higher for the endovascular (EV)
patients, the procedural mortality, 30-day mortality, and
the paraplegia risk was lower for the EV group. These
combined data are similar to our published series.4
DISCUSSION
While there are no devices approved for treating tho-
racic transections, endovascular repair has rapidly become
the preferred method of management for BAI at most
major medical centers. Whether this is a result of the
decreased incidence of spinal cord ischemia, morbidity or
mortality is difficult to determine.
Several technical tips should be discussed to avoid acute
complications of device collapse and treatment failure. De-
vice selection (diameter, conformability, and configura-
tion) is critical in obtaining treatment success. Devices
should be oversized approximately10%, however, current
devices do not address aortic diameters that are less than 18
mm in diameter (frequently seen in the younger popula-
tion). In addition, current devices lack distal aortic arch
conformity. Both of these issues may contribute to device
failure via device collapse and nonexclusion of the lesion.5
It is for this reason that some vascular specialists prefer to
use infrarenal aortic cuffs in an attempt to obtain better
outcomes. Understand, however, that multiple compo-
nents may also lead to treatment failure.
Left SCA coverage is not always required, and device
positioning should be based upon ideal device location to
ensure exclusion of the injury. This may require coverage in
a significant number, but not all patients. It is therefore
critical to have adequate vertebral imaging to avoid poste-
rior strokes. One must also keep in mind that more proxi-
mal device deployments have been associated with an in-
creased incidence of stroke in patients being treated for
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duce paraplegia risks for patients with aneurysmal disease,
the risk of paraplegia with EV repair of BAI is almost
nonexistent with only one reported case.9
As a result of the limited invasiveness of the procedure,
certain trauma patients can be treated in a more expeditious
fashion. In patients with concomitant head injuries, there
may be a benefit compared with delayed open repair, by
allowingmore aggressive management of blood pressure to
maximizing cerebral perfusion. Whether this will result in
improved outcomes remains to be seen.
CONCLUSION
Repair of BAI has undergone significant change in the
past 5 years. Imaging and device selection are critical to
obtain successful outcomes. Disease specific devices that
will accommodate the smaller aortic sizes and distal arch
conformity that are encountered in this distinct patient
population is crucial in allowing this therapy to move
forward in the future.
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